Physician profile
Brigett Garner
NPI 1154388908
$2,349.19
in general payments reported to CMS, 2019-2025
26 companies · $559 in 2025
The $559 reported for 2025 was more than what 87% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $359 · 2022: $462 · 2023: $498 · 2024: $471 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $428.46 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $323.02 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $252.60 | 2021-2025 | |
| Astellas Pharma US INC | $196.12 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $190.20 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $121.20 | 2021-2025 | Slynd |
| Organon LLC | $117.57 | 2022-2025 | Nexplanon |
| Biogen, INC. | $76.68 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $75.31 | 2024-2025 | |
| Scynexis, INC. | $72.57 | 2022 | |
| Medtronic, INC. | $63.76 | 2025 | Interstim |
| Baxter Healthcare | $58.04 | 2023-2025 | Tisseel |
| Coopersurgical, INC. | $57.23 | 2021-2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $52.85 | 2021 | |
| Millicent US INC | $31.93 | 2024-2025 | Intrarosa, Femring, Femlyv |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $31.09 | 2021-2022 | |
| Agile Therapeutics, INC. | $29.46 | 2021-2022 | |
| Viiv Healthcare Company | $29.22 | 2025 | Apretude |
| Aspira Women'S Health INC | $21.89 | 2024 | Ova1 |
| Smith+Nephew, INC. | $19.55 | 2025 | Pico 7, Pico 14 |
| Gynesonics, INC. | $18.51 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $18.31 | 2022 | |
| Evofem Biosciences, INC. | $18.00 | 2023 | Phexxi |
| Pfizer INC. | $17.49 | 2022 | |
| Lilly USA, LLC | $14.11 | 2025 | Zepbound |
| Exact Sciences Corporation | $14.02 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brigett Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.